ONT Onterris, Inc.
Onterris, Inc. operates as an environmental services company in the United States, Australia, Canada, and internationally. It operates in two segments: Consulting and Treatment, and Measurement and Analysis. The Consulting and Treatment segment provides environmental consulting, engineering, and implementation services to help clients assess, manage, and mitigate environmental risks across the lifecycle of their operations and projects. It supports environmental assessments, regulatory permitting, toxicology consulting, emergency preparedness, and response and environmental audits and permits; and offers engineering, design, and implementation solutions to treat contaminated water and remediate soil. The Measurement and Analysis segment offers environmental testing and laboratory services. It tests and analyzes air, water, and soil to determine concentrations of contaminants, as well as the toxicological impact of contaminants on flora, fauna, and human health. This segment's offerings include source and ambient air testing and monitoring, and leak detection, as well as air, soil, stormwater, wastewater, and drinking water analysis. It comprises a soil and water testing lab specializing in hydrocarbon and inorganic contamination analysis. The company was formerly known as Montrose Environmental Group, Inc. and changed its name to Onterris, Inc. in April 2026. Onterris, Inc. was founded in 2012 and is headquartered in North Little Rock, Arkansas.…
Industry Peers
Waste ManagementKey Statistics
About Onterris (NYSE: ONT)
›
Onterris (NYSE: ONT) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Waste Management industry, part of the Industrials sector, and reports about 3,500 employees.
The shares were at 23.35 USD on 19 November 2026, down 4.0% over 52 weeks. Its 52-week range is 12.26 USD to 30.00 USD: the price is 22.2% below the high and 90.5% above the low.
Its market capitalisation is 820.75M USD.
Onterris reports return on equity of -0.2%, an operating margin of 1.3% and revenue down 9.7% year over year.
Its debt exceeds its cash by 366.85M USD, a debt-to-equity ratio of 0.80. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 21.00 USD is 10.1% below the current price. The next earnings report is expected on 24 February 2027.